Addex Therapeutics (ADXN) Prepaid Assets (2018 - 2026)
Addex Therapeutics (ADXN) posted Prepaid Assets of $281128.7 for Q1 2026, up 1278.91% sequentially from $20387.8 in Q4 2025, and down 23.32% YoY from $366603.3 in Q1 2025.
Addex Therapeutics (ADXN) Prepaid Assets (2018 - 2026) Analysis & Trends
Addex Therapeutics has reported Prepaid Assets for 9 years, with the latest figure at $281128.7 in Q1 2026.
- Quarterly Prepaid Assets fell 23.32% year-over-year to $281128.7 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $281128.7 (down 23.32% YoY) and the FY2025 annual result came in at $19653.9, down 89.81% from the prior year.
- Prepaid Assets rose to $281128.7 in Q1 2026 per ADXN's latest filing, from $20387.8 in the prior quarter.
- Over five years, Prepaid Assets peaked at $2.0 million in Q1 2022 and troughed at $20387.8 in Q4 2025.
- A 5-year average of $617851.4 and a median of $307616.3 in 2024 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2022 and 2025: Prepaid Assets jumped 110.26% in 2022, then sank 89.47% in 2025.
- Over 5 years, Prepaid Assets stood at $280674.9 in 2022, then dropped by 12.84% to $244644.9 in 2023, then dropped by 20.84% to $193658.0 in 2024, then tumbled by 89.47% to $20387.8 in 2025, then jumped by 1278.91% to $281128.7 in 2026.
- According to Business Quant data, Prepaid Assets over the past three periods registered $281128.7, $20387.8, and $149281.8 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Addex Therapeutics | 534.71 Mn | 534.71 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 281,128.75 |
| Dec 31, 2025 | 20,387.81 |
| Sep 30, 2025 | 149,281.83 |
| Jun 30, 2025 | 303,275.87 |
| Mar 31, 2025 | 366,603.34 |
| Dec 31, 2024 | 193,658.04 |
| Sep 30, 2024 | 226,611.28 |
| Jun 30, 2024 | 307,616.27 |
| Mar 31, 2024 | 746,488.79 |
| Dec 31, 2023 | 244,644.94 |
| Sep 30, 2023 | 696,057.59 |
| Jun 30, 2023 | 1.12 Mn |
| Mar 31, 2023 | 956,049.36 |
| Dec 31, 2022 | 280,674.90 |
| Sep 30, 2022 | 846,647.33 |
| Jun 30, 2022 | 1.79 Mn |
| Mar 31, 2022 | 1.98 Mn |
| Dec 31, 2021 | 1.21 Mn |
| Sep 30, 2021 | 1.46 Mn |
| Jun 30, 2021 | 1.78 Mn |